Lardon F, Snoeck H W, Berneman Z N, Van Tendeloo V F, Nijs G, Lenjou M, Henckaerts E, Boeckxtaens C J, Vandenabeele P, Kestens L L, Van Bockstaele D R, Vanham G L
Laboratory of Experimental Haematology, University of Antwerp, Belgium.
Immunology. 1997 Aug;91(4):553-9. doi: 10.1046/j.1365-2567.1997.00295.x.
We report the generation of dendritic cells (DC) starting from CD34+ bone marrow (BM) progenitor cells, using a two-stage culture system in which, besides granulocyte-macrophage colony-stimulating factor (GM-CSF) and tumour necrosis factor-alpha (TNF-alpha), stem-cell factor (SCF) was added during the first 5 days, while interleukin-4 (IL-4) and/or interferon-gamma (IFN-gamma) were added during the secondary culture period of 9 days. Addition of IL-4 favoured the outgrowth of CD1a+, HLA-DR+, CD4+, CD40+, CD80+ but CD14- cells with dendritic morphology and strong antigen-presenting capacity. Addition of IFN-gamma selectively induced HLA-DR and CD86 but did not up-regulate CD1a expression or antigen-presenting capacity of the differentiated cells. An antagonism between IL-4 and IFN-gamma could further be confirmed in that, as compared with IL-4 alone, the simultaneous addition of IL-4 and IFN-gamma to GM-CSF plus TNF-alpha during maturation reduced both the phenotypical (CD1a, CD4, CD40) and functional characteristics of DC. Using receptor-specific TNF-alpha mutants, we investigated the relative involvement of TNF-alpha receptors R1 and R2 in the generation of DC. The induction of CD1a and HLA-DR, as well as the increase in allostimulatory capacity were dependent on TNF-R1 triggering, whereas triggering through TNF-R2 had no measurable effect. We conclude first, that the expansion of DC from BM progenitors could most effectively be enhanced in a two-stage culture assay using SCF, GM-CSF, TNF-alpha and IL-4; second, that the effect of TNF-alpha in DC generation involves signalling via the TNF-R1 receptor; and third, that IFN-gamma counteracts some of the effects of IL-4 in DC generation.
我们报道了从CD34+骨髓祖细胞开始生成树突状细胞(DC)的过程,采用两阶段培养系统,除了粒细胞-巨噬细胞集落刺激因子(GM-CSF)和肿瘤坏死因子-α(TNF-α)外,在最初5天添加干细胞因子(SCF),而在9天的二次培养期添加白细胞介素-4(IL-4)和/或干扰素-γ(IFN-γ)。添加IL-4有利于具有树突状形态和强大抗原呈递能力的CD1a+、HLA-DR+、CD4+、CD40+、CD80+但CD14-细胞的生长。添加IFN-γ选择性诱导HLA-DR和CD86,但未上调分化细胞的CD1a表达或抗原呈递能力。IL-4和IFN-γ之间的拮抗作用可进一步得到证实,因为与单独使用IL-4相比,在成熟过程中同时向GM-CSF加TNF-α中添加IL-4和IFN-γ会降低DC的表型(CD1a、CD4、CD40)和功能特性。使用受体特异性TNF-α突变体,我们研究了TNF-α受体R1和R2在DC生成中的相对作用。CD1a和HLA-DR的诱导以及同种异体刺激能力的增加依赖于TNF-R1的触发,而通过TNF-R2的触发没有可测量的影响。我们首先得出结论,在使用SCF、GM-CSF、TNF-α和IL-4的两阶段培养试验中,从骨髓祖细胞扩增DC最为有效;其次,TNF-α在DC生成中的作用涉及通过TNF-R1受体的信号传导;第三,IFN-γ抵消了IL-4在DC生成中的一些作用。